SCIENCEJun 12 · 08:30 UTCSTAT NEWSDavid J. Skorton

Opinion: I’ve spent 40 years in research. I have never seen a threat to science like the new grantmaking rule

The article highlights medical advancements like survivable childhood leukemia and cancer immunotherapy, crediting the American research enterprise. It criticizes a new federal grantmaking rule as a threat to scientific progress.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

childhood leukemiatopiccancer immunotherapytopicgenetic diseasestopicAmerican scientific research enterpriseorganizationGPStopicmodern semiconductortopicInternettopicFederal Governmentorganization

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

SCIENCEJun 3 · 19:18 UTC
Trump’s proposed grant rules could destroy US science, researcher warns
SCIENCEJun 11 · 07:00 UTC
The ‘commander’s intent’ and science
HEALTHMay 22 · 13:29 UTC
STAT+: Pharmalittle: We’re reading about a Parkinson’s drug setback, a Merck lung cancer therapy, and more
HEALTHApr 26 · 00:12 UTC
Why Has There Been So Little Progress on Alzheimer's Disease?
SCIENCEMay 31 · 11:00 UTC
Top U.S. science funder slows research grants to universities
SCIENCEJun 5 · 01:15 UTC
How Trump officials might gain control of research grants